Navigation Links
Promising medication counteracts constipation caused by opioid painkillers
Date:7/16/2014

Opioids strong morphine-based painkillers are widely prescribed to patients experiencing chronic severe pain. While these drugs are very effective for treating and managing pain, they have one particularly bothersome side effect: constipation. A new drug, called naloxegol, could bring relief. In stage 3 trials reported in the New England Journal of Medicine, KU Leuven and international researchers provide new evidence that the drug relieves constipation without dulling opioids' pain-relieving effects.

Up until a decade ago, physicians rarely prescribed opioids, reserving them primarily for the terminally sick. Today, opioid-based drugs have proliferated thanks to their 'user-friendliness' and effectiveness. Millions of patients take opioids on a daily basis to manage lower back pain and chronic joint problems. Opioids also play a critical role in pain management regimes for cancer patients.

However, opioids have a number of side effects, including nausea, vomiting and notoriously constipation. Opioids block pain by binding to 'mu-receptors' in the brain. But they also bind to mu-receptors in the bowels, and this causes constipation.

Some sixty percent of patients that take opioid pain relievers experience constipation. For some, the bother is so great that they choose to stop taking the drug.

A newly developed opioid antagonist called naloxegol may offer relief. Stage 3 testing by an international team of researchers led by Belgian gastroenterologist Jan Tack (University Hospitals Leuven) confirms the drug's efficacy.

Naloxegol is based on the same active molecule as naloxone, a drug developed in the 1960s to counter the effects of opioid overdose. Naloxone is commonly used to wake patients from opioid-induced anesthesia after surgery.

To arrive at naloxegol, the researchers modified the molecular structure of naloxone. The result is an orally administered, once-a-day pill for patients experiencing opioid-induced constipation.

The researchers tested the pill's efficacy in two phase 3 studies with promising results. Naloxegol was shown to maintain opioids' pain-killing effect in the brain and block their effects in the bowels. Bowel function in all of the 1,400 test subjects returned to normal and accompanying stomach pain and other discomforts decreased. No patients experienced a diminished pain-relieving effect as a result of the drug.

While the studies addressed in the paper focused on patients taking opioids for non-cancer pain such as back pain and other musculoskeletal ailments, similar studies are now underway to examine the effect of naloxegol in patients with chronic cancer-related pain.

Final regulatory approval for the drug is pending in the United States and Europe.


'/>"/>

Contact: Jan Tack
jan.tack@med.kuleuven.be
321-634-4225
KU Leuven
Source:Eurekalert

Related medicine news :

1. New therapy for pancreatic cancer patients shows promising results
2. Immune therapy for advanced bladder cancer yields promising results
3. Experimental trial represents promising step toward universal antidote for snakebite
4. Sleep researchers at SRI International identify promising new treatment for narcolepsy
5. Researchers present findings on promising biomarker for esophageal cancer
6. Vibrating capsule shows promising results in treating chronic constipation
7. Danish nasal filter looks promising for allergy sufferers
8. Scientists explore promising new option for first line of attack in lymphoma
9. GW researcher finds gene therapy a promising tool for cardiac regeneration
10. NUS researchers make new discovery of protein as a promising target for treatment of ATC
11. LA BioMed researchers report on promising new therapy for devastating genetic disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... 24, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5 ... or PMS . , Most women of child-bearing age will experience the symptoms ... headaches, fatigue, and other discomfort. For some women, the effects are severe ...
(Date:1/24/2017)... ... 2017 , ... “Choosing Wisdom-Solomon’s Proverbs Reclaimed”: an inspiring ... prostitution, adultery, anger, and common sense. , “Choosing Wisdom-Solomon’s Proverbs Reclaimed” is ... Coats. In September of 1983, they flew to Haiti to focus on missions ...
(Date:1/24/2017)... ... 24, 2017 , ... “Spiritual Vitamins: A Spiritual Energy Booster”: ... “Spiritual Vitamins: A Spiritual Energy Booster” is the creation of published author, Mathai ... new book engages the mind and spirit in a quest for fulfillment and ...
(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual ... Octagon of Spiritual Balances” is the creation of published author, Pastor Bernard J. Weathers, ... Weathers holds a bachelor degree in religious education and a master degree in theology. ...
(Date:1/24/2017)... ... January 24, 2017 , ... Attention women who want ... suggests that autologous fat grafting—taking one’s own fat and putting it in other ... , Cosmetic Surgeon and Medical Director of MilfordMD Cosmetic Dermatology Surgery & ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... Jan. 23, 2017 INTRODUCTION Injectable drug ... conventional syringes with vials to prefilled syringes, auto-injectors, ... devices have become preferred devices for parenteral administration ... has been rising strongly over the past several ... now adopting this format for delivering drugs. The ...
(Date:1/24/2017)... , January 23, 2017 ... for life sciences, announces agClinical 3.3, the latest version ... further enables life science organizations to confidently and efficiently ... and better manage the electronic trial master file so ... ...
(Date:1/23/2017)... NEW YORK , Jan. 23, 2017 ... Development Partners and Driving the Stability Testing Outsourcing Market ... testing market addresses market sizing, emerging trends, and technologies, ... the market. The base year is 2015 and forecasts ... market is expected to grow at a CAGR of ...
Breaking Medicine Technology: